Minority Health and Health Equity | FDA

Minority Health and Health Equity | FDA

FDA OMHHE is Seeking Public Feedback on Strategic Priorities

The Food and Drug Administration (FDA or the Agency) is opening a public docket to solicit input and comments from interested stakeholders, including racial and ethnic minority, underrepresented, and underserved populations in establishing strategic priorities for the Office of Minority Health and Health Equity (OMHHE). This will help the Agency ensure that important health concerns are carefully considered in establishing priorities.

We encourage interested stakeholders to submit comments on the areas and types of engagement FDA's OMHHE should prioritize in the coming year(s), and potential mechanisms that can be used to implement them (e.g., through collaborations and partnerships).

Submit either electronic or written comments by February 28, 2020. You can find more information, and submit your comments, on the Federal Register website.